GlassScriptPhysician profile
Emily Hinton
NPI 1376509760
$2,710.12
in general payments reported to CMS, 2019-2025
26 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $331 · 2021: $612 · 2022: $721 · 2023: $165 · 2024: $312 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,000.09 | 2019-2023 | |
| Exeltis, USA INC. | $173.56 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $158.60 | 2021-2024 | Novasure, Myosure Tissue Removal Device, Aptima |
| Pfizer INC. | $153.35 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $140.93 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $101.39 | 2021-2025 | |
| Baxter Healthcare | $97.69 | 2022 | |
| Biogen, INC. | $93.82 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $88.20 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $86.83 | 2021-2022 | |
| Medtronic, INC. | $69.77 | 2021-2024 | Interstim |
| Applied Medical Resources Corporation | $67.23 | 2021 | |
| Millicent US INC | $65.86 | 2025 | Femlyv, Intrarosa |
| Biohaven Pharmaceuticals, INC. | $59.74 | 2021 | |
| Myovant Sciences INC. | $46.63 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $43.92 | 2019 | |
| Organon LLC | $41.96 | 2023-2025 | Nexplanon |
| Covidien LP | $39.67 | 2019-2020 | |
| Therapeuticsmd, INC. | $37.81 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $29.79 | 2021 | |
| Minerva Surgical, INC | $28.46 | 2024 | |
| Coopersurgical, INC. | $21.66 | 2022 | |
| Allergan, INC. | $17.75 | 2020 | |
| Merck Sharp & Dohme LLC | $16.36 | 2019 | |
| Medline Industries LP | $15.73 | 2022 | |
| Novo Nordisk INC | $13.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.